Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Bogaard (Amsterdam, Netherlands). Systemic consequences of pulmonary arterial hypertension. International Congress 2019 – State of the art session: Pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Pulmonary arterial hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=126 Year: 2005 Pulmonary arterial hypertension Source: Breathe 2010; 6: 377-380 Year: 2010 Pulmonary arterial hypertension Source: Eur Respir Monogr 2013; 62: 70-84 Year: 2013 Pulmonary arterial hypertension Source: Eur Respir Monogr 2014; 66: 232-246 Year: 2014 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=397 Year: 2007 Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Trends in pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 7-12 Year: 2009 Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Importance of environmental factors in pulmonary embolism and pulmonary arterial hypertension Source: International Congress 2019 – New trends in the management of pulmonary vascular disease Year: 2019 Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary arterial hypertension case Source: International Congress 2016 – ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II Year: 2016 The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Pregnancy in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 431-437 Year: 2016 Pulmonary arterial hypertension in children Source: Eur Respir J 2003; 21: 155-176 Year: 2003 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011